09:30 – 12:10 (160’), Orche Ⅰ&Ⅱ
14:00 - 17:25 (205’), Orche Ⅰ
13:30 – 15:40 (130’), Orche Ⅱ
16:00 – 18:00 (120’), Orche Ⅱ
This session explores the latest trends in hyper‑personalized beauty tech, focusing on AI‑based skin diagnostics and home‑beauty devices.
It covers personalized care driven by skin data, clinical and regulatory strategies, and global commercialization approaches that integrate devices with cosmetics.
| Time | Title | Speaker |
|---|---|---|
| 13:30 - 13:40 (10’) | Opening (Welcome Remarks, Congratulatory Messages, etc.) | Jung Younghoon KHIDI Planning Director |
| 13:40 - 14:10 (30’) |
Home Beauty Device Market Trends - Opportunities in self‑care and hyper‑personalized beauty tech |
Zoe Shin APR Co., Ltd. Executive Director |
| 14:10 – 14:40 (30’) |
AI Skin Analysis & Prescription Technology Linked with Home Devices - Personalized care routines powered by skin big data |
Munseob Lee Electronics and Telecommunications Research Institute (ETRI) Principal Researcher |
| 14:40 – 15:10 (30’) |
Clinical Evidence and Regulatory Compliance for Home Beauty Device Efficacy & Safety - Dual regulation of devices and cosmetics, and overseas certifications (FDA · CPNP · NMPA) |
Baek Jihoon Human Clinical Trial Center Director |
| 15:10 – 15:40 (30’) |
Taking Home Beauty Devices to the Global Stage - Global B2C success strategies through the integration of device, app, and dedicated cosmetic products. |
Seo Youngseok Wontech Co., Ltd. CTO |
You can click on each speaker to view their Professional Experience and Abstract.

APR Co., Ltd.
Executive Director
After B.S., M.S., and Ph.D. in Biomedical Engineering from Yonsei University, he conducted R&D in intelligent biomedical signal processing, home-use medical devices, dental X-ray systems, and various other medical technologies. He currently serves as Head Director of the R&D Center at APR, leading the development of home beauty devices and aesthetic medical devices.
It presents key trends driven by the growth of the beauty device market, including the expansion of home care and skin/body applications, integration with cosmetics, AI-driven hyper-personalization, and global market expansion, highlighting personalized self-care and technological differentiation as key drivers of future competitiveness.

Electronics and Telecommunications Research Institute (ETRI)
Principal Researcher
Dr. Munseob Lee is a Principal Researcher at ETRI who has developed diagnostic and analytical technologies using 3D imaging and AI. His current interests include AI-based skin diagnosis using skin imaging data, personalized beauty and healthcare technologies, and their industrial applications.
This talk presents AI- and optical-based skin diagnostics, data-driven personalized care, and integration with personalized beauty devices for intelligent skincare.

Human Clinical Trial Center
Director
Dr. Ji Hwoon Baek earned his Ph.D. in Immunology from Yonsei University and has 25 years of experience evaluating the safety and efficacy of cosmetics, foods, and beauty devices at Aekyung Industrial and DERMAPRO. He currently serves as Director of the Human Skin Clinical Trial Center, providing clinical tests and regulatory advisory services, as well as Chair of the Safety Science Division of the Society of Cosmetic Scientists of Korea and Vice President of the Korean Society for Skin Barrier Research.
This presentation explores the dual regulatory framework for home beauty devices and cosmetic combination products, covering human study design for safety and efficacy, market entry pathways in the US, EU, and China, and claims substantiation strategies.

Wontech Co., Ltd.
CTO
Dr. Young-Seok Seo majored in Physics at Chungnam National University and has served as Vice President/CTO of Wontech Research Institute at Wontech Co., Ltd. since 2008. He conducted research in laser and optics at the Korea Atomic Energy Research Institute (KAERI), Japan Science and Technology Agency (JST), and Osaka University's Institute of Laser Engineering (ILE). He developed and commercialized energy-based medical devices, including lasers as well as RF and ultrasound technologies, and received the IR52 Jang Yeong-sil Award and a commendation from the Minister of Health and Welfare.
This presentation covers the market entry strategy, trial-and-error, and decision-making process for a company seeking to leverage its expertise in professional medical aesthetic devices to combine devices, apps, and cosmetics and succeed in the global home beauty B2C market.